首页 | 本学科首页   官方微博 | 高级检索  
检索        

米氮平与氟西汀治疗脑卒中后抑郁焦虑障碍对照研究
引用本文:肖立群,陈景清.米氮平与氟西汀治疗脑卒中后抑郁焦虑障碍对照研究[J].山东精神医学,2009,22(2):117-118.
作者姓名:肖立群  陈景清
作者单位:肖立群,XIAO Liqun(山东省泰安市精神病医院,271000);陈景清,CHEN Jingqing(山东省济宁市精神痛防治院)  
摘    要:目的评价米氮平与氟西汀对脑卒中后抑郁焦虑障碍的疗效和副反应。方法53例脑卒中后抑郁焦虑患者随机分为两组,分别以米氮平及氟西汀治疗。疗程6周。于治疗前、治疗后1、2、4、6周末采用汉米尔顿抑郁量表(HAMD)、汉米尔顿焦虑量表(HAMA)、副反应量表(TESS)评定疗效和副反应。结果米氮平组显效率为74.199/6,氟西汀组为50%,差异有显著性(χ^2=3.91,P〈0.05)。米氮平组起效快。两组HAMA总分和HAMD在焦虑/躯体化、睡眠障碍因子分方面差异有显著性(P〈0.05)。米氮平组的不良反应较氟西汀组少而轻。结论米氮平治疗脑卒中后抑郁焦虑障碍起效快、安全、疗效肯定,是临床治疗中可选用的方法之一。

关 键 词:脑血管意外  抑郁焦虑  米氮平  氟西汀

A comparative study of mirtazapine and fluoxetine in the treatment of post-stroke depression-anxiety disorder
XIAO Liqun,CHEN Jingqing.Taian Center of Mental Health,Sh,ong ,China.A comparative study of mirtazapine and fluoxetine in the treatment of post-stroke depression-anxiety disorder[J].Shangdong Archives of Psychiatry,2009,22(2):117-118.
Authors:XIAO Liqun  CHEN JingqingTaian Center of Mental Health  Sh  ong  China
Institution:XIAO Liqun,CHEN Jingqing.Taian Center of Mental Health,Sh,ong 271000,China
Abstract:Objective To evaluate the efficacy and side effects of mirtazapine and fluoxetine in the treatment of post-stroke depression-anxiety disorder.Methods A total of 53 patients with post-stroke depression-anxiety disorder were randomly divided into mirtazapine group and fluoxetine group for the treatment of 6 weeks.The efficacy were assessed by Hamilton Depression Rating Scale(HAMD) and Hamilton Anxiety Scale(HAMA) and the safety was assessed by Treatment Emergent Symptom Scale(TESS) before the treatment and at...
Keywords:Cerebrovascular disorder Depression Anxiety Mirtazapine Fluoxetine  
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号